ES2181824T3 - Profarmacos de derivados de paclitaxel. - Google Patents

Profarmacos de derivados de paclitaxel.

Info

Publication number
ES2181824T3
ES2181824T3 ES96109044T ES96109044T ES2181824T3 ES 2181824 T3 ES2181824 T3 ES 2181824T3 ES 96109044 T ES96109044 T ES 96109044T ES 96109044 T ES96109044 T ES 96109044T ES 2181824 T3 ES2181824 T3 ES 2181824T3
Authority
ES
Spain
Prior art keywords
professionals
paclitaxel derivatives
paclitaxel
derivatives
pharmaceutical formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96109044T
Other languages
English (en)
Inventor
Paul M Scola
John F Kadow
Dolatrai M Vyas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ES2181824T3 publication Critical patent/ES2181824T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6551—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring
    • C07F9/65512—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)

Abstract

LA PRESENTE INVENCION TRATA DE NUEVOS DERIVADOS DE PACLITAXEL, SU USO COMO AGENTES ANTITUMOR, Y FORMULACIONES FARMACEUTICAS.
ES96109044T 1995-06-06 1996-06-05 Profarmacos de derivados de paclitaxel. Expired - Lifetime ES2181824T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46924795A 1995-06-06 1995-06-06

Publications (1)

Publication Number Publication Date
ES2181824T3 true ES2181824T3 (es) 2003-03-01

Family

ID=23863053

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96109044T Expired - Lifetime ES2181824T3 (es) 1995-06-06 1996-06-05 Profarmacos de derivados de paclitaxel.

Country Status (23)

Country Link
EP (1) EP0747385B1 (es)
JP (1) JPH08337589A (es)
KR (1) KR100375956B1 (es)
CN (1) CN1066151C (es)
AR (1) AR002756A1 (es)
AT (1) ATE222259T1 (es)
AU (1) AU695959B2 (es)
CA (1) CA2176191A1 (es)
CZ (1) CZ291516B6 (es)
DE (1) DE69622933T2 (es)
DK (1) DK0747385T3 (es)
ES (1) ES2181824T3 (es)
HU (1) HUP9601524A3 (es)
IL (1) IL118526A (es)
MX (1) MX9601994A (es)
NO (1) NO315233B1 (es)
NZ (1) NZ286723A (es)
PL (1) PL187883B1 (es)
PT (1) PT747385E (es)
RU (1) RU2162082C2 (es)
SG (1) SG72692A1 (es)
TW (1) TW354293B (es)
ZA (1) ZA964261B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395770B1 (en) * 1995-10-26 2002-05-28 Baker Norton Pharmaceuticals, Inc. Method and compositions for administering taxanes orally to human patients
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
CN1550231A (zh) * 1997-05-27 2004-12-01 �Ϳˡ�ŵ��ҩ�����޹�˾ 给予病人口服紫杉烷类药物的方法和组合物
US6204257B1 (en) 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
US6538038B1 (en) * 1999-02-18 2003-03-25 Oxigene, Inc. Compositions and methods for use in targeting vascular destruction
US6362172B2 (en) * 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
AU776122B2 (en) 2000-02-02 2004-08-26 Florida State University Research Foundation, Inc. C7 carbonate substituted taxanes as antitumor agents
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
US6916942B2 (en) 2000-02-03 2005-07-12 Bristol-Myers Squibb Company Process for the preparation of C-4 carbonate taxanes
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US7063977B2 (en) 2001-08-21 2006-06-20 Bristol-Myers Squibb Company Enzymatic resolution of t-butyl taxane derivatives
KR20030049023A (ko) * 2001-12-13 2003-06-25 주식회사 코오롱 방사선 감작제용 파클리탁셀 유도체
CN1960721A (zh) 2004-03-05 2007-05-09 佛罗里达州立大学研究基金有限公司 C7乳酰氧基取代的紫杉烷类
EP3345632A1 (en) * 2005-02-18 2018-07-11 Abraxis BioScience, LLC Drugs with improved hydrophobicity for incorporation in medical devices
AU2014235462C1 (en) 2013-03-15 2018-11-01 Concert Pharmaceuticals, Inc. Deuterated palbociclib
WO2015009889A1 (en) 2013-07-18 2015-01-22 Concert Pharmaceuticals, Inc. Deuterated intedanib derivatives and their use for the treatment of proliferative disorders
JP7110094B2 (ja) * 2015-11-19 2022-08-01 バイオヘイブン・ファーマシューティカル・ホールディング・カンパニー・リミテッド 医薬化合物のアミンプロドラッグ

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO310238B1 (no) * 1992-12-24 2001-06-11 Bristol Myers Squibb Co Kjemiske forbindelser og farmasöytisk preparat samt anvendelse av slike preparater
CA2129288C (en) * 1993-08-17 2000-05-16 Jerzy Golik Phosphonooxymethyl esters of taxane derivatives

Also Published As

Publication number Publication date
MX9601994A (es) 1997-08-30
DE69622933D1 (de) 2002-09-19
PT747385E (pt) 2002-11-29
CZ291516B6 (cs) 2003-03-12
PL314637A1 (en) 1996-12-09
SG72692A1 (en) 2000-05-23
KR100375956B1 (ko) 2003-04-21
RU2162082C2 (ru) 2001-01-20
IL118526A0 (en) 1996-10-16
HUP9601524A3 (en) 2000-03-28
CZ156396A3 (en) 1996-12-11
HU9601524D0 (en) 1996-07-29
DK0747385T3 (da) 2002-12-16
NZ286723A (en) 1998-03-25
NO315233B1 (no) 2003-08-04
HUP9601524A2 (en) 1997-05-28
AU695959B2 (en) 1998-08-27
IL118526A (en) 2001-05-20
CA2176191A1 (en) 1996-12-07
JPH08337589A (ja) 1996-12-24
AR002756A1 (es) 1998-04-29
NO962231L (no) 1996-12-09
CN1066151C (zh) 2001-05-23
ATE222259T1 (de) 2002-08-15
ZA964261B (en) 1997-11-27
PL187883B1 (pl) 2004-10-29
NO962231D0 (no) 1996-05-31
CN1144805A (zh) 1997-03-12
AU5471896A (en) 1996-12-19
KR970000222A (ko) 1997-01-21
EP0747385A1 (en) 1996-12-11
TW354293B (en) 1999-03-11
EP0747385B1 (en) 2002-08-14
DE69622933T2 (de) 2003-04-24

Similar Documents

Publication Publication Date Title
ES2181824T3 (es) Profarmacos de derivados de paclitaxel.
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
PT639577E (pt) Eteres fosfono-oximetilicos ou metiltiometilicos de derivados do taxano como agentes anti-tumor
CR9879A (es) Moduladores de ccr5 (divisional de la solicitud n° 6392)
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
HN1998000168A (es) Derivados de la tienapirimidina y de la tienapiridina utiles como agentes anticancerigenos.
ES2181744T3 (es) Hidratos de paclitaxel cristalinos.
PT971717E (pt) Amino-acucar citotoxico e derivados de acucar afins de indolopirrolocarbazois
ES2147739T3 (es) Fosfonooximetil-eteres de derivados de taxano.
FI964583A0 (fi) Tokoferolikoostumuksia biologisesti aktiivisten aineiden antamiseksi
SV1997000079A (es) Dihidrato d de olancepina ref. x- 11062t
ATE231872T1 (de) Thiazolopyrimidinderivate
ES2169147T3 (es) Derivados de beta-carbolina agonistas de la melatonina, sus procedimientos de preparacion y su utilizacion a titulo de medicamento.
ES2168463T3 (es) Derivados fenilicos trisustituidos.
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
SE9801494D0 (sv) Novel use
ATE207076T1 (de) Ara-c derivate
DK0773782T3 (da) Terpenderivater (sarcodictyiner) anvendelse som antitumormidler
PT1011329E (pt) Paclitaxeis de 7-metiltio-oxometilo e 7-metiltiodioxometilo
HN2000000057A (es) Derivados de i - trifluorometil-4-hidroxi-7-piperidinil- aminometilcromano.
ES2129053T3 (es) Nuevos derivados de fosfolipidos.
ES2174081T3 (es) Uso de n-(pirrol-1-il)piridinaminas sustituidas y no sustituidas como agentes anticonvulsivos.
ECSP993296A (es) Moduladores de ccr5
ECSP993298A (es) Moduladores de ccr5
MX9303606A (es) Derivados de azabicicloheptano n-sustituidos, su obtencion y uso.